
    
      Study Objectives:

      1. Continue to collect and assess safety data on Q Fever Vaccine, Phase I, Inactivated,
      Freeze-Dried, NDBR 105, and 2) Provide vaccine that potentially protects personnel at risk
      for occupational exposure to Q Fever and collect data on incidence of occupational Q Fever
      infection (subclinical and clinical) in immunized personnel.
    
  